Jim Cramer Says He is Not a “Backer” of GE HealthCare Technologies (GEHC)

A caller asked if GE HealthCare Technologies Inc. (NASDAQ:GEHC) is worth another look, and in response, Cramer said:

“Okay, now you know, you’re a club member, you know I sold a lot in the high 80s and then gave up on the rest. The reason I did was because it’s inconsistent and too controlled by China, not America. So I am not going to be a backer. I am going to say the fabled [don’t buy, don’t buy, don’t buy].”

A radiologist in a lab examining a computed tomography scan of a patient.

GE HealthCare (NASDAQ:GEHC) develops, manufactures, and markets a range of products, services, and digital tools that support the diagnosis, treatment, and monitoring of patients. The company reported a 3% year-over-year increase in revenue for the first quarter of 2025. The adjusted EBIT margin rose to 15.0% from 14.7%, and adjusted EPS increased to $1.01 from $0.90. Furthermore, free cash flow declined to $98 million, down from $274 million in the same quarter last year.

While we acknowledge the potential of GEHC to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk.  If you are looking for an AI stock that is more promising than GEHC and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: Jim Cramer Commented on These 6 Natural Gas Players and 13 Stocks on Jim Cramer’s Radar Recently

Disclosure: None.